Cargando…

EPD1504: a novel μ-opioid receptor partial agonist attenuates obsessive–compulsive disorder (OCD)-like behaviors

Low doses of μ-opioid receptor (MOR) agonists rapidly ameliorate symptoms in treatment-resistant obsessive–compulsive disorder (OCD) patients (10–50% of OCD patients). However, the utility of MOR agonists is limited by their safety liabilities. We developed a novel MOR partial agonist (EPD1540) that...

Descripción completa

Detalles Bibliográficos
Autores principales: Youngblood, Beth, Medina, Julio C., Gehlert, Donald R., Schwartz, Neil
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10349350/
https://www.ncbi.nlm.nih.gov/pubmed/37457777
http://dx.doi.org/10.3389/fpsyt.2023.1170541

Ejemplares similares